Vitiligo Treatment in Noida

Evidence-led vitiligo treatment by Dr. Reena Sharma, MD Dermatology — combining NB-UVB phototherapy, prescription topicals (including ruxolitinib where appropriate) and melanocyte transfer surgery for stable cases.

1

Vitiligo carries an unfair social stigma in India. The clinical reality is more hopeful: it is one of the more treatable autoimmune skin conditions, with several evidence-based therapies that achieve significant repigmentation in most patients. This page explains how we approach vitiligo at Derma Essence — and what is realistic at every stage.

Setting expectations honestly

We will be straightforward with you: vitiligo is treatable, not curable. With consistent treatment, most patients see:

  • 60 to 80 percent repigmentation in face, neck and trunk patches
  • Slower / partial response in lips, fingertips, and over bony joints
  • Stabilisation of active disease (no new patches) within 3 to 6 months
  • Need for ongoing maintenance to prevent relapse

The two questions we answer first

Before treatment plan, we determine:

  1. Is the disease active or stable? Active = new patches in last 6 months, existing patches expanding. Stable = no change for 12+ months. Treatment differs significantly between the two.
  2. Are there autoimmune comorbidities? Thyroid disease, type 1 diabetes, alopecia areata, vitamin B12/D3 deficiency. We screen and address these — they affect treatment response.

The treatment toolkit

1

Topical therapy (always)

Tacrolimus 0.1% ointment — calcineurin inhibitor, safe for face and folds. Mid-potency corticosteroid for body patches (rotated to avoid skin thinning). Ruxolitinib 1.5% cream for facial patches in adults and adolescents — the first JAK inhibitor approved for vitiligo, strong recent evidence.

2

NB-UVB phototherapy

The cornerstone of moderate-to-extensive vitiligo treatment. Narrowband UVB (311nm) cabinet exposure 2 to 3 times weekly, starting at sub-erythemal doses and increasing over weeks. Sessions are 30 seconds to 5 minutes. Excimer laser (308nm) for small targeted patches.

3

Oral therapy (selected patients)

Mini-pulse oral steroids for active, rapidly-progressing disease to halt new patch formation. Sometimes immunomodulators in collaboration with rheumatology. Always weighed carefully — these are not first-line.

4

Surgery (stable disease only)

For patients with stable, non-active vitiligo who have not responded to medical therapy. Melanocyte transfer (non-cultured cellular suspension), split-thickness grafts, or punch grafting depending on patch size and location. Excellent results for stable cases. More on vitiligo surgery.

Pricing

Vitiligo Treatment — diagnosis & therapy

Option Price Notes
Diagnostic consultation + Wood lamp examination ₹1,500 Includes 3-month plan
NB-UVB phototherapy session ₹600 Per session — typically 2-3x weekly
Excimer laser session ₹2,500 Targeted phototherapy for small patches
Topical regimen (3-month supply) ₹3,500 Tacrolimus + corticosteroids + ruxolitinib (where appropriate)
Melanocyte transfer surgery (per session) ₹35,000 For stable, non-active vitiligo — see Vitiligo Surgery page

NB-UVB courses are typically 30 to 60 sessions across 3 to 6 months. Cost depends on disease extent.

Daily skincare while on treatment

  • SPF 50 daily, even indoors. Sunburn can trigger new patches (Koebner phenomenon). Reapply every 2 hours when outdoors.
  • Avoid trauma — tight clothing, scratching, deep waxing. Trauma sites can develop new patches.
  • Manage stress — strong evidence that severe stress can trigger flares. Sleep, exercise, mental health support all matter.
  • Adequate vitamin D and B12 — many vitiligo patients are deficient. Test, supplement, repeat.

The emotional side

Visible vitiligo is hard. Patches on hands, face, and lips affect confidence — particularly in Indian social contexts. We treat the medical side; we also strongly recommend a few things alongside:

  • Camouflage makeup (Dermablend, Vitiliderm) for events while treatment progresses
  • Counselling support if vitiligo is affecting mental health (very common, no shame in seeking it)
  • Connecting with other patients — vitiligo support communities exist online and locally

Vitiligo treatment is a partnership. Consistent on your side (sessions, topicals, sun protection); evidence-led on ours. Book a consultation for a personalised assessment and 3-month plan.

Quick answers

Vitiligo Treatment — Frequently Asked Questions

Is vitiligo curable?
Honest answer: vitiligo is treatable rather than curable. With consistent treatment, we can repigment 60 to 80 percent of patches in most patients, and stabilise active disease in nearly all. Some areas (lips, fingertips, joints) are harder to treat than others.
Is vitiligo contagious?
No. Vitiligo is an autoimmune condition where the immune system mistakenly attacks pigment-producing cells (melanocytes). It cannot be caught from contact, sharing food, or sharing personal items.
What causes vitiligo?
A combination of genetic predisposition + autoimmune triggers (severe stress, illness, skin trauma). About 30 percent of patients have a family history. Often associated with thyroid disease, type 1 diabetes, and other autoimmune conditions — we screen for these.
Does sun help or worsen vitiligo?
Both, depending on context. Controlled phototherapy (NB-UVB) is the most effective vitiligo treatment. Uncontrolled sun exposure can trigger new patches via the Koebner phenomenon (patches at trauma sites, including sunburn). Always use SPF 50 outdoors.
How long until I see repigmentation?
Initial repigmentation usually shows at 8 to 12 weeks. Significant cosmetic improvement at 4 to 6 months. Lips, fingertips and bony areas can take 12+ months. Patience is non-negotiable — vitiligo treatment is a long game.
What is the new ruxolitinib cream?
Ruxolitinib (Opzelura) is a JAK inhibitor cream FDA-approved for vitiligo in 2022 — the first new vitiligo medication in decades. Strong evidence for facial repigmentation. We prescribe selectively where appropriate; it is expensive and not first-line for everyone.
When is surgery an option?
For patients with stable, non-active vitiligo (no new patches for 12+ months) who have not responded to medical therapy. We offer melanocyte transfer (NCMS / split-thickness grafts) at our clinic. Not for active or unstable disease.
Can children be treated?
Yes — and earlier is often better. Topical therapy is well-tolerated in children. NB-UVB can be used in children from age 6 or 7. We tailor protocols carefully for paediatric patients.